As shown in Figure 6, most of miRNAs significantly modulated in most of cancers including glioma, pancreatic, bladder, non‐long carcinoma, prostate, thyroid cancers, and also p53 pathway, cell cycle, pyrimidine metabolism, cell cycle, and DNA replication. The gene discussed is TP53; the disease is thyroid cancer.